We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

112 hedge funds and large institutions have $521M invested in Intersect ENT, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.05M

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

0% more funds holding

Funds holding: 112112 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

25% less capital invested

Capital invested by funds: $690M → $521M (-$169M)

Holders
112
Holders Change
Holders Change %
0%
% of All Funds
2.46%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
20
Increased
44
Reduced
33
Closed
20
Calls
$16.1M
Puts
$3.05M
Net Calls
+$13.1M
Net Calls Change
+$2.12M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$771K +$144K +7,900 +21%
EGM
52
Engineers Gate Manager
New York
$730K -$972K -53,389 -55%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$701K +$12.7K +697 +2%
RA
54
Royce & Associates
New York
$680K -$673K -37,000 -48%
CS
55
Candriam SCA
Luxembourg
$680K
ECM
56
Endurant Capital Management
California
$643K -$4.24M -232,746 -86%
Allianz Asset Management
57
Allianz Asset Management
Germany
$639K +$684K +37,581 New
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$575K
AllianceBernstein
59
AllianceBernstein
Tennessee
$503K
SG Americas Securities
60
SG Americas Securities
New York
$477K -$31.4K -1,726 -6%
Susquehanna International Group
61
Susquehanna International Group
Pennsylvania
$451K -$435K -23,878 -47%
AQR Capital Management
62
AQR Capital Management
Connecticut
$445K +$22.9K +1,259 +5%
Tudor Investment Corp
63
Tudor Investment Corp
Connecticut
$432K +$462K +25,388 New
PPA
64
Parametric Portfolio Associates
Washington
$431K +$59.2K +3,250 +15%
BA
65
Boston Advisors
Massachusetts
$426K -$264K -14,500 -37%
WMSA
66
Weiss Multi-Strategy Advisers
New York
$425K +$455K +25,000 New
TRSOTSOK
67
Teachers Retirement System of the State of Kentucky
Kentucky
$418K
Millennium Management
68
Millennium Management
New York
$400K -$16.2M -888,575 -97%
Dimensional Fund Advisors
69
Dimensional Fund Advisors
Texas
$389K +$416K +22,866 New
CG
70
Cutler Group
California
$384K +$241K +13,231 +141%
Balyasny Asset Management
71
Balyasny Asset Management
Illinois
$380K +$407K +22,361 New
AG
72
Aperio Group
California
$358K +$206K +11,315 +117%
BIM
73
Bogle Investment Management
Massachusetts
$358K +$383K +21,066 New
AIG
74
American International Group
New York
$330K -$2.48K -136 -0.7%
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$321K -$91 -5 -0%

XENT Hedge Fund Activity: Q3 2019 in Review

112 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2019, worth a combined $521M — down 25% from $690M a quarter earlier.

Fund positioning in XENT was balanced in Q3 2019: 20 funds opened new positions, 20 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was UBS Group, adding an estimated $25.3M. The largest seller was Invesco, cutting an estimated $31.5M.

  • 112 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $521M of Intersect ENT, Inc stock for Q3 2019, down 25% quarter-over-quarter.
  • 20 funds opened new Intersect ENT, Inc positions in Q3 2019 and 20 closed out, a net change of 0 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2019 was UBS Group, an estimated $25.3M added.
  • The largest Intersect ENT, Inc seller in Q3 2019 was Invesco, an estimated $31.5M sold.

Based on aggregated 13F filings for Q3 2019.